Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: a population-based study in the UK.
Hassan AlwafiLi WeiAbdallah Y NaserPajaree MongkhonGary TseKenneth Keng Cheung ManJ Simon BellJenni IlomakiGang FangIan C K WongPublished in: BMJ open (2020)
Prescribing of OACs in individuals with T2DM increased from 2001 to 2015. Since the introduction of DOACs, there has been a clear shift in prescribing towards these agents. Future studies are needed to assess the safety of coadministration of OAC medications and antidiabetic therapy with T2DM.
Keyphrases
- primary care
- adverse drug
- atrial fibrillation
- venous thromboembolism
- current status
- type diabetes
- direct oral anticoagulants
- emergency department
- stem cells
- glycemic control
- mesenchymal stem cells
- bone marrow
- metabolic syndrome
- skeletal muscle
- insulin resistance
- cell therapy
- electronic health record
- smoking cessation